Evogene’s Lavie Bio announces licensing agreement with Corteva

Lavie Bio, a subsidiary of Evogene (EVGN) announced a licensing agreement with Corteva (CTVA). The agreement grants Corteva exclusive rights to further develop and commercialize the lead bio-fungicide product candidates targeting fruit rots and powdery mildew, which were discovered and developed by Lavie Bio. The agreement comes after two years of independent field validation conducted by both companies.